Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation

Detalhes bibliográficos
Autor(a) principal: Castro, Josimar Macedo de
Data de Publicação: 2021
Outros Autores: Stein, Dirson João, Medeiros, Helouise Richardt, Oliveira, Carla de, Torres, Iraci Lucena da Silva
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/231294
Resumo: Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes.
id UFRGS-2_bfe6d7546588220b55abb6467529b8d5
oai_identifier_str oai:www.lume.ufrgs.br:10183/231294
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Castro, Josimar Macedo deStein, Dirson JoãoMedeiros, Helouise RichardtOliveira, Carla deTorres, Iraci Lucena da Silva2021-10-27T04:26:05Z20212296-861Xhttp://hdl.handle.net/10183/231294001132857Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes.application/pdfengFrontiers in nutrition. Lausanne. vol. 8 (2021), 648893, 8 f.NiacinamidaRestrição calóricaMúsculosObesidadeNicotinamide ribosideCaloric restrictionObesityNeuroinflammationMuscle massSkeletal muscle tissueHypothalamusBrainNicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigationEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001132857.pdf.txt001132857.pdf.txtExtracted Texttext/plain40872http://www.lume.ufrgs.br/bitstream/10183/231294/2/001132857.pdf.txt88934c5cdfdbaf87d554c977e4064bb5MD52ORIGINAL001132857.pdfTexto completo (inglês)application/pdf932764http://www.lume.ufrgs.br/bitstream/10183/231294/1/001132857.pdf0d081c1b074ffbe714c62b0dbeeb4af0MD5110183/2312942021-11-20 05:54:36.746357oai:www.lume.ufrgs.br:10183/231294Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2021-11-20T07:54:36Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
title Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
spellingShingle Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
Castro, Josimar Macedo de
Niacinamida
Restrição calórica
Músculos
Obesidade
Nicotinamide riboside
Caloric restriction
Obesity
Neuroinflammation
Muscle mass
Skeletal muscle tissue
Hypothalamus
Brain
title_short Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
title_full Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
title_fullStr Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
title_full_unstemmed Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
title_sort Nicotinamide riboside neutralizes hypothalamic inflammation and increases weight loss without altering muscle mass in obese rats under calorie restriction : a preliminary investigation
author Castro, Josimar Macedo de
author_facet Castro, Josimar Macedo de
Stein, Dirson João
Medeiros, Helouise Richardt
Oliveira, Carla de
Torres, Iraci Lucena da Silva
author_role author
author2 Stein, Dirson João
Medeiros, Helouise Richardt
Oliveira, Carla de
Torres, Iraci Lucena da Silva
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Castro, Josimar Macedo de
Stein, Dirson João
Medeiros, Helouise Richardt
Oliveira, Carla de
Torres, Iraci Lucena da Silva
dc.subject.por.fl_str_mv Niacinamida
Restrição calórica
Músculos
Obesidade
topic Niacinamida
Restrição calórica
Músculos
Obesidade
Nicotinamide riboside
Caloric restriction
Obesity
Neuroinflammation
Muscle mass
Skeletal muscle tissue
Hypothalamus
Brain
dc.subject.eng.fl_str_mv Nicotinamide riboside
Caloric restriction
Obesity
Neuroinflammation
Muscle mass
Skeletal muscle tissue
Hypothalamus
Brain
description Obesity treatments, such as calorie restriction (CR), eventually lead to muscle wasting and higher rates of neuroinflammation, whereas hypothalamic inflammatory conditions impair body weight (BW) control. Nicotinamide riboside (NR) has been proposed against obesity but with little evidence on skeletal muscle tissue (SMT) and neuroinflammation. Therefore, we aimed to investigate the effects of CR on SMT and on hypothalamic inflammatory biomarkers in obese adult male Wistar rats, and whether NR supplementation alone or in combination with CR affects these parameters. Obesity was induced in rats through a cafeteria diet for 6 weeks. After that, a group of obese rats was exposed to CR, associated or not associated with NR supplementation (400 mg/kg), for another 4 weeks. As a result, obese rats, with or without CR, presented lower relative weight of SMT when compared with eutrophic rats. Rats under CR presented lower absolute SMT weight compared with obese and eutrophic rats, in addition to presenting elevated hypothalamic levels of TNF-α. NR supplementation, in all groups, enhanced weight loss and increased relative weight of the SMT. Furthermore, in animals under CR, NR reversed increases TNF-α levels in the hypothalamus. In this study, these data, although succinct, are the first to evidence the effects of NR on SMT and neuroinflammation when associated with CR, especially in obesity conditions. Therefore, this provides preliminary support for future studies in this investigative field. Furthermore, NR emerges as a potential adjuvant for preventing muscle mass loss in the weight loss processes.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-10-27T04:26:05Z
dc.date.issued.fl_str_mv 2021
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/231294
dc.identifier.issn.pt_BR.fl_str_mv 2296-861X
dc.identifier.nrb.pt_BR.fl_str_mv 001132857
identifier_str_mv 2296-861X
001132857
url http://hdl.handle.net/10183/231294
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Frontiers in nutrition. Lausanne. vol. 8 (2021), 648893, 8 f.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/231294/2/001132857.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/231294/1/001132857.pdf
bitstream.checksum.fl_str_mv 88934c5cdfdbaf87d554c977e4064bb5
0d081c1b074ffbe714c62b0dbeeb4af0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801225040639819776